Cyberonics Stumbles and ANS Lends a Hand
Executive Summary
An unexpected and unfavorable ruling from the FDA has left Cyberonics officials angry and frustrated and has put in jeopardy the depression opportunity the company was counting on. Also on Cyberonics' plate: an unwelcome merger bid from rival neurostimulation company, ANS.